Anna Torrång - Concepedia

Author

Anna Torrång

Karolinska Institutet

Also Known As

A Torrång, A. Torrang, A. Torrång, ANNA TORRÅNG, Anna Torrång, Anna Torrång

Publications

930

Citations

H-Index

Concepts

All Affiliations

Karolinska Institutet Harvard University Karolinska University Hospital Statens Serum Institut Uppsala University Hospital

About

Anna Torrång is an author at Karolinska Institutet specializing in medicine, epidemiology, and public health.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	95
2	Public Health	2	2	84
3	Education	1	1	131
4	Health Sciences	1	1	11
5	Child Development	1	1	131

Anna Torrång

Publications

921

Citations

H-Index

Page 1

	Year	Citations
Ultraviolet Radiation Exposure and Risk of Malignant Lymphomas Karin E. Smedby, Henrik Hjalgrim, Mads Melbye, JNCI Journal of the National Cancer Institute	2005	257
Testicular Cancer Incidence in Eight Northern European Countries: Secular and Recent Trends Lorenzo Richiardi, Rino Bellocco, Hans‐Olov Adami, Cancer Epidemiology Biomarkers & Prevention	2004	253
Birth Weight and Attention-Deficit/Hyperactivity Symptoms in Childhood and Early Adolescence Christina M. Hultman, Anna Torrång, Catherine Tuvblad, Journal of the American Academy of Child & Adolescent Psychiatry Childhood ObesityAdhdChild PsychologyEarly Childhood DevelopmentPediatrics	2007	131
Scholastic achievement at age 16 and risk of schizophrenia and other psychoses: a national cohort study James H. MacCabe, Mats Lambe, Sven Cnattingius, Psychological Medicine	2007	115
Synergy between Cigarette Smoking and Human Papillomavirus Type 16 in Cervical Cancer <i>In situ</i> Development Anthony S. Gunnell, Trung N. Tran, Anna Torrång, Cancer Epidemiology Biomarkers & Prevention	2006	70
Nutrient Intake and Risk of Non-Hodgkin's Lymphoma Ellen T. Chang, K. M. Balter, Anna Torrång, American Journal of Epidemiology ObesityNutritionBody CompositionNutritional EpidemiologyDietary Exposure	2006	58
Re‐use of case–control data for analysis of new outcome variables Marie Reilly, Anna Torrång, Åsa Klint Statistics in Medicine Empirical Case StudyCausal InferenceNew Outcome VariablesPreventive MedicinePublic Health	2005	26
Patient‐reported outcomes in relapsed/refractory multiple myeloma treated with melflufen plus dexamethasone: analyses from the Phase II HORIZON study Alessandra Larocca, Xavier Leleu, Cyrille Touzeau, British Journal of Haematology Hematological MalignancyTranslational MedicineOncologyMelphalan FlufenamideSymptomatic Treatment	2021	11

Page 1